Stoke Therapeutics Inc
Ownership
Ownership Structure
Who owns Stoke Therapeutics Inc (STOK)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 70.7% of the shares are freely tradable; institutional investors hold 120.3%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 9.11 | 5,877,357 | +9.1 | 06/30/2026 |
| RTW INVESTMENTS, LLC | 8.72 | 5,623,525 | +0.0 | 06/30/2026 |
| FMR Inc | 8.23 | 5,313,100 | -1.3 | 06/30/2026 |
| Lynx1 Capital Management, LP | 6.26 | 4,038,404 | -15.2 | 06/30/2026 |
| Redmile Group, LLC | 6.12 | 3,945,920 | -5.2 | 06/30/2026 |
| Wellington Management Company LLP | 5.45 | 3,519,301 | +13.7 | 06/30/2026 |
| Morgan Stanley - Brokerage Accounts | 5.35 | 3,452,795 | +0.9 | 06/30/2026 |
| Baker Bros Advisors LP | 5.17 | 3,336,697 | +0.0 | 06/30/2026 |
| The Toronto-Dominion Bank | 4.92 | 3,173,258 | +0.0 | 06/30/2026 |
| State Street Corp | 4.42 | 2,852,240 | +25.3 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Kaye Edward M. MD | Director | 124,557 | 3,300,761 $ | Aug 18, 2026 | direct |
| Allan Jonathan | GENERAL COUNSEL & CORP SEC | 20,598 | 545,847 $ | Oct 2, 2026 | direct |
| Ticho Barry | CHIEF MEDICAL OFFICER | 19,059 | 505,064 $ | Oct 1, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 2, 2026 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sell | 627 | 26.33 | 16,509 |
| Oct 1, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 1,051 | 26.16 | 27,494 |
| Sep 1, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 1,600 | 31.06 | 49,691 |
| Sep 1, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 3,945 | 30.51 | 120,370 |
| Aug 18, 2026 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sell | 145 | 32.47 | 4,708 |
| Aug 18, 2026 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sell | 2,716 | 32.01 | 86,932 |
| Aug 18, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 242 | 32.47 | 7,857 |
| Aug 18, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 4,525 | 32.01 | 144,833 |
| Aug 18, 2026 | Kaye Edward M. MD | Director | Sell | 637 | 32.47 | 20,682 |
| Aug 18, 2026 | Kaye Edward M. MD | Director | Sell | 11,930 | 32.01 | 381,846 |
| Aug 14, 2026 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Other | 6,000 | 0.00 | – |
| Aug 14, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | Other | 10,000 | 0.00 | – |
| Aug 14, 2026 | Kaye Edward M. MD | Director | Other | 26,250 | 0.00 | – |
| Aug 3, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 1,269 | 29.45 | 37,377 |
| Aug 3, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 5,907 | 28.95 | 171,008 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.